E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes
Clinical trial NCT01692197 · COMPLETED
Trial details
- NCT number
- NCT01692197
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2017-06-07
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.